Drug · DIN 02542277
TRIKAFTA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 27, 2023; first marketed October 27, 2023.
- Drug Identification Number (DIN)
- 02542277
- Company (DIN owner)
- Vertex Pharmaceuticals (Canada) IncorporatedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Granules
- Route
- Oral
- Therapeutic class (ATC)
- Ivacaftor, tezacaftor and elexacaftor R07AX32
- Class
- Human
- Record last updated
- February 6, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ELEXACAFTOR | 100 MG | |
| TEZACAFTOR | 50 MG | |
| IVACAFTOR | 75 MG | |
| IVACAFTOR | 75 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 16, 2023: NOC 31866Supplement to a New Drug Submission (SNDS) · Expand indication. Addition of new dosage form . Addition of new strengths
Other DINs named TRIKAFTA
- DIN 02517140 · Marketed
- DIN 02526670 · Marketed
- DIN 02542285 · Marketed